Comparative Pharmacology
Head-to-head clinical analysis: DECA DURABOLIN versus STANOZIDE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DECA DURABOLIN versus STANOZIDE.
DECA-DURABOLIN vs STANOZIDE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Nandrolone decanoate is an anabolic steroid that binds to androgen receptors, increasing protein synthesis and promoting muscle growth. It also stimulates erythropoietin production, increasing red blood cell mass.
Androgen receptor agonist; increases protein synthesis and muscle mass by binding to androgen receptors, leading to enhanced nitrogen retention and erythropoiesis.
Intramuscular injection of 100-200 mg every 1-3 weeks for anabolic effects; for replacement therapy, 50-100 mg every 2-4 weeks.
100 mg orally twice daily or 200 mg orally once daily; immediate-release formulation.
None Documented
None Documented
Terminal half-life of nandrolone decanoate is 4.3 hours for the decanoate ester, but the active metabolite nandrolone has a prolonged half-life of 6-7 days due to slow release from intramuscular depot and enterohepatic recirculation; clinical effects persist for 3-4 weeks.
Terminal elimination half-life is 24-30 hours, supporting once-daily dosing. Clinical context: Steady-state achieved after approximately 5-7 days.
Primarily renal (90% as metabolites, 5% unchanged); fecal elimination accounts for <5%.
Primarily hepatic metabolism (approximately 80%) with biliary excretion of metabolites; renal excretion of unchanged drug is minimal (<5%). Fecal elimination accounts for <15%.
Category C
Category C
Anabolic Steroid
Anabolic Steroid